MICHAEL ROOS: Open Payments
NPI 1477655223 · PAHRUMP, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$567 in 22 payments from 12 companies in 2025. Trend: 2023 $486 · 2024 $637 · 2025 $567
Food & beverage: $468Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $120 |
| UCB, Inc. | 3 | $95 |
| Amgen Inc. | 4 | $63 |
| E.R. Squibb & Sons, L.L.C. | 3 | $58 |
| ABBVIE INC. | 2 | $49 |
| PFIZER INC. | 2 | $49 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| STRATA Skin Sciences, Inc. | 1 | $22 |
| GENZYME CORPORATION | 1 | $20 |
Products named: TREMFYA, Bimzelx, OTEZLA, Sotyktu, DUPIXENT, SKYRIZI, CIBINQO, COSENTYX.
Industry payments across NV — which companies pay providers there.
